Intellia Therapeutics Inc (NTLA)
12.53
-0.27
(-2.11%)
USD |
NASDAQ |
Jan 07, 15:53
Intellia Therapeutics Market Cap: 1.276B for Jan. 7, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Regeneron Pharmaceuticals Inc | 80.22B |
BridgeBio Pharma Inc | 5.445B |
Perspective Therapeutics Inc | 251.43M |
Electromed Inc | 255.94M |
Xtant Medical Holdings Inc | 69.50M |
Market Cap Related Metrics
PS Ratio | 27.91 |
PEG Ratio | -1.369 |
Price to Book Value | 1.326 |
Price | 12.53 |
Earnings Yield | -43.42% |
PEGY Ratio | -1.369 |